Evidence map›Paper›PMID 22028855›Full record

ArticlePloS one2011

Lipoteichoic acid in Streptomyces hygroscopicus: structural model and immunomodulatory activities.

Marlène Cot, Aurélie Ray, Martine Gilleron, Alain Vercellone, Gérald Larrouy-Maumus, Elise Armau, Sophie Gauthier, Gérard Tiraby, Germain Puzo, Jérôme Nigou

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Generation of glucosylatedRSC chemical biology · 2021
    Article
  6. Streamlined Synthesis and Evaluation of Teichoic Acid Fragments.Chemistry (Weinheim an der Bergstrasse, Germany) · 2018
    Article
  7. Lipoteichoic acid from anBiomedical reports · 2015
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Marlène CotCNRS, Institut de Pharmacologie et de Biologie Structurale, Toulouse, France.
Aurélie Ray
Martine Gilleron
Alain Vercellone
Gérald Larrouy-Maumus
Elise Armau
Sophie Gauthier
Gérard Tiraby
Germain Puzo
Jérôme Nigou
InvivoGen (France) · FRUniversité Toulouse III - Paul Sabatier · FRCentre National de la Recherche Scientifique · FRUniversité Fédérale de Toulouse Midi-Pyrénées · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gram positive bacteria produce cell envelope macroamphiphile glycopolymers, i.e. lipoteichoic acids or lipoglycans, whose functions and biosynthesis are not yet fully understood. We report for the first time a detailed structure of lipoteichoic acid isolated from a Streptomyces species, i.e. Streptomyces hygroscopicus subsp. hygroscopicus NRRL 2387T. Chemical, MS and NMR analyses revealed a polyglycerolphosphate backbone substituted with α-glucosaminyl and α-N-acetyl-glucosaminyl residues but devoid of any amino-acid substituent. This structure is very close, if not identical, to that of the wall teichoic acid of this organism. These data not only contribute to the growing recognition that lipoteichoic acid is a cell envelope component of gram positive Actinobacteria but also strongly support the recently proposed hypothesis of an overlap between the pathways of lipoteichoic acid and wall teichoic acid synthesis in these bacteria. S. hygroscopicus lipoteichoic acid induced signalling by human innate immune receptor TLR2, confirming its role as a microbe-associated molecular pattern. Its activity was partially dependant on TLR1, TLR6 and CD14. Moreover, it stimulated TNF-α and IL-6 production by a human macrophage cell line to an extent similar to that of Staphylococcus aureus lipoteichoic acid. These results provide new clues on lipoteichoic acid structure/function relationships, most particularly on the role of the polyglycerolphosphate backbone substituents.

Indexed as

Models, MolecularCytokinesHEK293 CellsHumansImmunologic FactorsLipopolysaccharidesSignal TransductionStreptomycesStructure-Activity RelationshipTeichoic AcidsToll-Like Receptor 2CytokinesImmunologic FactorsLipopolysaccharideslipoteichoic acidTeichoic AcidsTLR2 protein, humanToll-Like Receptor 2

Identifiers

PMID22028855
PMCPMC3196553
OpenAlexW1986987260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.